Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy
Article in Frontiers in Immunology (February 2021)
The most recent citing publication is shown below. View this citation on Dimensions.
Agressive Lymphomas
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Epidemiology of Aggressive Lymphomas
-
Altmetric BadgeChapter 2 Pathology and Molecular Pathogenesis of DLBCL and Related Entities
-
Altmetric BadgeChapter 3 Pathology and Molecular Pathogenesis of Burkitt Lymphoma and Lymphoblastic Lymphoma
-
Altmetric BadgeChapter 4 Pathology and Molecular Pathogenesis of T-Cell Lymphoma
-
Altmetric BadgeChapter 5 Standard of Care in First-Line Therapy of DLBCL
-
Altmetric BadgeChapter 6 Standard of Care Relapsed DLBCL
-
Altmetric BadgeChapter 7 Burkitt Lymphoma
-
Altmetric BadgeChapter 8 Human Immunodeficiency Virus-Related Lymphomas
-
Altmetric BadgeChapter 9 Primary CNS Lymphoma
-
Altmetric BadgeChapter 10 Extranodal Localization of Aggressive Lymphoma
-
Altmetric BadgeChapter 11 CD20-Negative Aggressive Lymphomas
-
Altmetric BadgeChapter 12 Standard of Care in T-Cell Lymphoma
-
Altmetric BadgeChapter 13 Aggressive Lymphoma in Children and Adolescents
-
Altmetric BadgeChapter 14 Role of Modern Imaging with FDG-PET/CT in Aggressive Lymphoma
-
Altmetric BadgeChapter 15 Kinase Inhibitors in Large Cell Lymphoma
-
Altmetric BadgeChapter 16 Immunological Approaches
-
Altmetric BadgeChapter 17 Therapeutic Modulators of Apoptosis and Epigenetics in Aggressive Lymphoma
-
Altmetric BadgeChapter 18 Targeted Therapeutics for Lymphoma: Using Biology to Inform Treatment
Attention for Chapter 3:
Pathology and Molecular Pathogenesis of Burkitt Lymphoma and Lymphoblastic Lymphoma